Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Adrenergic Receptors (Adrenoceptors): Classification01:27

Adrenergic Receptors (Adrenoceptors): Classification

Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oral Burden of Sjögren Disease: A Systematic Review and Meta-analysis.

Journal of dental research·2026
Same author

Discovering opioid slang on social media: A Word2Vec approach with reddit data.

Drug and alcohol dependence reports·2024
Same author

[Ferritinemia, a complex marker of iron metabolism].

Revue medicale de Liege·2021
Same author

Integrated twin-screw wet granulation, continuous vibrational fluid drying and milling: A fully continuous powder to granule line.

International journal of pharmaceutics·2020
Same author

Effectiveness of the Gerundium Youth Educating Program in Hungary.

Transplantation proceedings·2019
Same author

Next-generation sequencing identifies novel mitochondrial variants in pituitary adenomas.

Journal of endocrinological investigation·2019

Related Experiment Video

Updated: Jul 16, 2026

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
10:53

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents

Published on: July 3, 2013

Canine ventricular myocyte beta2-adrenoceptors are not functionally coupled to L-type calcium current.

Z Nagykaldi1, D Kem, R Lazzara

  • 1Department of Internal Medicine, University of Oklahoma Health Sciences Center and the Veterans Administration Medical Center, Oklahoma City, USA.

Journal of Cardiovascular Electrophysiology
|October 12, 1999
PubMed
Summary

Beta-adrenergic agonists enhance the L-type calcium current (I(CaL)) in canine heart cells exclusively through beta1-adrenergic receptors (beta1AR), not beta2AR. This finding clarifies the specific receptor pathways involved in cardiac calcium regulation.

More Related Videos

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
14:39

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples

Published on: April 21, 2014

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
11:00

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes

Published on: September 18, 2017

Related Experiment Videos

Last Updated: Jul 16, 2026

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
10:53

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents

Published on: July 3, 2013

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
14:39

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples

Published on: April 21, 2014

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
11:00

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes

Published on: September 18, 2017

Area of Science:

  • Cardiovascular Physiology
  • Adrenergic Receptor Signaling
  • Cardiac Electrophysiology

Background:

  • The functional coupling of beta-adrenergic receptor (betaAR) subtypes, specifically beta1AR and beta2AR, to the L-type calcium current (I(CaL)) is crucial for regulating cardiac contractility.
  • Understanding the distinct roles of beta1AR and beta2AR in modulating I(CaL) is essential for developing targeted cardiovascular therapies.

Purpose of the Study:

  • To elucidate the specific betaAR subtypes responsible for the functional coupling to I(CaL) in isolated canine ventricular myocytes.
  • To differentiate the contributions of beta1AR and beta2AR to the modulation of I(CaL) using selective agonists and antagonists.

Main Methods:

  • Utilized whole-cell voltage clamp techniques with patch-type microelectrodes to measure I(CaL) in isolated canine ventricular myocytes.
  • Administered nonselective beta-adrenergic agonist isoproterenol (ISO) and selective beta2AR agonists zinterol (ZIN) and salbutamol (SAL).
  • Employed selective beta1AR antagonists (CGP 20712A, atenolol) and a beta2AR antagonist (ICI 118,551) to determine receptor specificity.

Main Results:

  • Isoproterenol (ISO) significantly increased I(CaL) by approximately 3.5-fold.
  • Zinterol (ZIN) and salbutamol (SAL) produced smaller, approximately 1.4-1.5 fold increases in I(CaL).
  • The stimulatory effects of ISO, ZIN, and SAL on I(CaL) were fully inhibited by beta1AR antagonists (CGP, atenolol) but not by the beta2AR antagonist (ICI).
  • Beta1AR antagonists (CGP) inhibited basal I(CaL), an effect abolished by forskolin, indicating actions upstream of adenylate cyclase.
  • The selective beta2AR agonist zinterol did not increase I(CaL) at lower concentrations.

Conclusions:

  • Beta-adrenergic agonists increase I(CaL) in canine ventricular myocytes primarily, if not exclusively, through the activation of beta1AR.
  • Beta2AR do not appear to significantly contribute to the direct stimulation of I(CaL) in this model system.
  • These findings highlight the dominant role of beta1AR in mediating the positive inotropic effects of beta-adrenergic stimulation via calcium current modulation.